Zobrazeno 1 - 10
of 702
pro vyhledávání: '"M. Anttila"'
Publikováno v:
European Psychiatry, Vol 67, Pp S59-S59 (2024)
Introduction Violence in psychiatric inpatient settings is a global challenge. Several methods have been developed and tested to help staff prevent the occurrence of violence on the wards. One novel and effective method is eDASA+APP, originating from
Externí odkaz:
https://doaj.org/article/a37a920d77ac45d3a968b6c04c6ec1be
Autor:
H. Sallinen, S. Janhonen, P. Pölönen, H. Niskanen, O. H. Liu, A. Kivelä, J. M. Hartikainen, M. Anttila, M. Heinäniemi, S. Ylä-Herttuala, M. U. Kaikkonen
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background High grade serous ovarian carcinoma (HGSOC) is the most common subtype of epithelial ovarian cancers (EOC) with poor prognosis. In most cases EOC is widely disseminated at the time of diagnosis. Despite the optimal cytoreductive s
Externí odkaz:
https://doaj.org/article/23d2fd5ddaae4e6cb92fdda372490d3a
Publikováno v:
European Psychiatry, Vol 64, Pp S126-S127 (2021)
Introduction In the literature, service users and informal caregivers have been critical towards psychiatric inpatient care. However, little is known about their fears related to hospital care. Objectives We describe service users’ and informal c
Externí odkaz:
https://doaj.org/article/a5be9e31940248a699ac71fc5d376210
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Matthew M. Anttila, Brianna M. Vickerman, Qunzhao Wang, David S. Lawrence, Nancy L. Allbritton
Publikováno v:
Analytical Chemistry. 93:16664-16672
Autor:
Johanna Lilja, Ella-Maria Vesilahti, Johanna M. Anttila, Hussein Al-Akhrass, Johanna Ivaska, Emilia Peuhu, Pauliina Munne, Mika Pietilä, Juha Klefström, Heidi M. Haikala
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 16, Iss 1, Pp 116-129 (2022)
Molecular Oncology, Vol 16, Iss 1, Pp 116-129 (2022)
In breast cancer, the currently approved anti‐receptor tyrosine‐protein kinase erbB‐2 (HER2) therapies do not fully meet the expected clinical goals due to therapy resistance. Identifying alternative HER2‐related therapeutic targets could off
Autor:
Joyce V. Lee, Filomena Housley, Christina Yau, Rachel Nakagawa, Juliane Winkler, Johanna M. Anttila, Pauliina M. Munne, Mariel Savelius, Kathleen E. Houlahan, Daniel Van de Mark, Golzar Hemmati, Grace A. Hernandez, Yibing Zhang, Susan Samson, Carole Baas, Marleen Kok, Laura J. Esserman, Laura J. van ‘t Veer, Hope S. Rugo, Christina Curtis, Juha Klefström, Mehrdad Matloubian, Andrei Goga
Publikováno v:
Nature Communications. 13
Autor:
Joyce V. Lee, Filomena Housley, Christina Yau, Rachel Nakagawa, Juliane Winkler, Johanna M. Anttila, Pauliina M. Munne, Mariel Savelius, Kathleen E. Houlahan, Daniel Van de Mark, Golzar Hemmati, Grace A. Hernandez, Yibing Zhang, Susan Samson, Carole Baas, Marleen Kok, Laura J. Esserman, Laura J. van ‘t Veer, Hope S. Rugo, Christina Curtis, Juha Klefström, Mehrdad Matloubian, Andrei Goga
Publikováno v:
Nature communications, vol 13, iss 1
Few patients with triple negative breast cancer (TNBC) benefit from immune checkpoint inhibitors with complete and durable remissions being quite rare. Oncogenes can regulate tumor immune infiltration, however whether oncogenes dictate diminished res
Autor:
G. Turrini, M. Purgato, F. Tedeschi, C. Acartürk, M. Anttila, T. Au, K. Carswell, R. Churchill, P. Cuijpers, F. Friedrich, C. Gastaldon, T. Klein, M. Kösters, T. Lantta, M. Nosè, G. Ostuzzi, D. Papola, M. Popa, M. Sijbrandij, L. Tarsitani, L. Todini, E. Uygun, M. Välimäki, L. Walker, J. Wancata, R. G. White, E. Zanini, M. van Ommeren, C. Barbui
Publikováno v:
Turrini, G, Purgato, M, Tedeschi, F, Acartürk, C, Anttila, M, Au, T, Carswell, K, Churchill, R, Cuijpers, P, Friedrich, F, Gastaldon, C, Klein, T, Kösters, M, Lantta, T, Nosè, M, Ostuzzi, G, Papola, D, Popa, M, Sijbrandij, M, Tarsitani, L, Todini, L, Uygun, E, Välimäki, M, Walker, L, Wancata, J, White, R G, Zanini, E, Van Ommeren, M & Barbui, C 2022, ' Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe : 12-month outcomes of a randomised controlled trial ', Epidemiology and Psychiatric Sciences, vol. 31, e39, pp. 1-10 . https://doi.org/10.1017/S2045796022000269
Epidemiology and Psychiatric Sciences, 31:e39, 1-10. Cambridge University Press
Turrini, G, Purgato, M, Tedeschi, F, Acartürk, C, Anttila, M, Au, T, Carswell, K, Churchill, R, Cuijpers, P, Friedrich, F, Gastaldon, C, Klein, T, Kösters, M, Lantta, T, Nosè, M, Ostuzzi, G, Papola, D, Popa, M, Sijbrandij, M, Tarsitani, L, Todini, L, Uygun, E, Välimäki, M, Walker, L, Wancata, J, White, R G, Zanini, E, van Ommeren, M & Barbui, C 2022, ' Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial ', Epidemiology and Psychiatric Sciences, vol. 31, e39 . https://doi.org/10.1017/S2045796022000269
Epidemiology and Psychiatric Sciences
Epidemiology and Psychiatric Sciences, 31:e39, 1-10. Cambridge University Press
Turrini, G, Purgato, M, Tedeschi, F, Acartürk, C, Anttila, M, Au, T, Carswell, K, Churchill, R, Cuijpers, P, Friedrich, F, Gastaldon, C, Klein, T, Kösters, M, Lantta, T, Nosè, M, Ostuzzi, G, Papola, D, Popa, M, Sijbrandij, M, Tarsitani, L, Todini, L, Uygun, E, Välimäki, M, Walker, L, Wancata, J, White, R G, Zanini, E, van Ommeren, M & Barbui, C 2022, ' Long-term effectiveness of Self-Help Plus in refugees and asylum seekers resettled in Western Europe: 12-month outcomes of a randomised controlled trial ', Epidemiology and Psychiatric Sciences, vol. 31, e39 . https://doi.org/10.1017/S2045796022000269
Epidemiology and Psychiatric Sciences
Aims: as refugees and asylum seekers are at high risk of developing mental disorders, we assessed the effectiveness of Self-Help Plus (SH + ), a psychological intervention developed by the World Health Organization, in reducing the risk of developing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e32c4a89b49a32fb4cc8a429ea82b36
https://hdl.handle.net/1871.1/122ac4b2-4b16-4e0b-8bfd-2f1758b80e1c
https://hdl.handle.net/1871.1/122ac4b2-4b16-4e0b-8bfd-2f1758b80e1c